Microvention AnEurysm & STroke Real-life Data cOllection

Launched by MICROVENTION-TERUMO, INC. · Jul 2, 2024

Keywords

ClinConnect Summary

The MAESTRO-1 study is collecting real-life data to learn more about treating patients with intracranial aneurysms, which are bulges in the blood vessels in the brain that can be dangerous if they rupture. This trial is specifically looking at patients who are treated with a MicroVention device, whether their aneurysm has burst or not. It’s important to note that this study is not testing a new treatment; rather, it is observing how well this existing device works in everyday clinical settings.

To participate, patients must be treated for an aneurysm with the MicroVention device, and they or their legal representatives must give consent for their data to be collected. However, individuals who cannot be easily followed up with or are part of other conflicting studies will not be eligible. If you join the study, you will help researchers better understand how this treatment works in practice, which can ultimately improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient or legally authorized representative (LAR) is informed of the data collection and gives non-opposition or consent prior to the data collection in accordance with institutional and geographic requirements.
• • Patient is treated for a ruptured or unruptured intracranial aneurysm using a commercially available MicroVention implant device as the primary treatment device and the decision to use this device has been made by the treating physician outside the context of the MAESTRO-1 study.
• Exclusion Criteria:
• • Patient is or is expected to be inaccessible for follow-up.
• • Patient is participating or intends to participate in another study that changes the site practice.
• • Patient has been previously enrolled into the MAESTRO-1 study.